Determinants of health literacy and its impact on illness perception in patients with multiple sclerosis: evidence from patient-reported outcomes Authors: Emine Rabia Koc, Naci Murat, Hakan Demirci, Furkan Saridas, Sanja Gluscevic, Sema Nur Minaz, Omer Faruk Turan, Tjalf Ziemssen Published: 2025 ABSTRACT AbstractBackgroundHealth literacy (HL) is a key determinant of health outcomes, especially in chronic neurological diseases such as multiple sclerosis (MS). Insufficient HL may impair the ability of patients to manage their condition, reduce treatment adherence and increase the use of healthcare.ObjectiveTo identify factors influencing HL among individuals with MS and to explore its association with illness perception and medication-related behaviours.MethodsBetween April and September 2023, we consecutively enrolled 330 patients with MS from a single outpatient clinic. We included individuals aged 18–65 years with functional literacy, and we did not exclude participants based on MS subtype, education level, disability status or treatment characteristics. We assessed HL using the Newest Vital Sign, cognition using the Montreal Cognitive Assessment (MoCA), emotional status using the Hospital Anxiety and Depression Scale, and illness perception using the Brief Illness Perception Questionnaire (BIP-Q). We also evaluated self-reported medication adherence and perceived treatment benefits. After excluding 11 participants with incomplete data, we analysed 319 complete responses in accordance with Strengthening the Reporting of Observational Studies in Epidemiology guidelines.ResultsOverall, 49.7% of participants demonstrated adequate HL. The HL correlated positively with MoCA scores and education (path coefficients: 0.117, 0.114) and negatively with disease duration, age and depression (−0.023,–0.029, −0.085). HL was positively associated with illness perception (BIP-Q coefficient: 1.558). The model explained 35.6% of the variance in HL and 5.7% in illness perception (R²=0.356; 0.057).ConclusionOur findings suggest that routine HL assessment and targeted educational interventions may enhance understanding, adherence and informed decision-making, ultimately improving disease management and outcomes in MS.Keywords: MULTIPLE SCLEROSIS, COGNITION, HEALTH POLICY & PRACTICE WHAT IS ALREADY KNOWN ON THIS TOPIC Health literacy (HL) affects clinical outcomes in chronic diseases such as multiple sclerosis (MS), yet its relationship with cognitive, emotional and demographic factors remains unclear. Health literacy (HL) affects clinical outcomes in chronic diseases such as multiple sclerosis (MS), yet its relationship with cognitive, emotional and demographic factors remains unclear. WHAT THIS STUDY ADDS This study shows that education, cognitive performance, age, disease duration and depressive symptoms are major determinants of HL and that higher HL is associated with stronger illness perception. This study shows that education, cognitive performance, age, disease duration and depressive symptoms are major determinants of HL and that higher HL is associated with stronger illness perception. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Routine HL screening and tailored educational interventions may improve treatment adherence, reduce misinformation and enhance patient-centred communication in MS care. Routine HL screening and tailored educational interventions may improve treatment adherence, reduce misinformation and enhance patient-centred communication in MS care. Background In today’s context, the ability of individuals to access accurate and reliable information from the right sources, comprehend that information and act appropriately is becoming increasingly crucial for sustaining healthy lives. Efforts in this domain have led to the emergence of health literacy (HL). HL can be defined as the ability of an individual to comprehend, interpret and act on medical information provided to them.1 Multiple sclerosis (MS) is a neurodegenerative disease affecting the central nervous system, characterised by acute, inflammatory and demyelinating features that concurrently impact axons.2 Like all chronic illnesses, in MS, patients need to be informed about their conditions, medications they are using, potential medication-related side effects and aspects they need to be attentive to during various stages of their lives, and must comprehend and implement this information accurately. Poor literacy hinders the ability of patients to understand the effects and side effects of prescription medications, leading to a misunderstanding of basic concepts related to their medical condition and treatment instructions. This can increase hospitalisation rates and worsen health outcomes.3 HL is an essential concept that needs to be considered in the management of individuals living with MS, a chronic disease that commences in young adulthood. The ability of people living with MS to actively manage their condition throughout the disease course, participate in treatment choices and remain conscious in the event of side effect development significantly relies on HL knowledge and skills. Awareness of HL also enables clinicians to personalise their approach to patients and improve overall patient care.3 As awareness of the importance of HL for patient-reported outcomes and quality of life increases, research targeting individuals with MS is also growing. Dehghani used the method of evolutionary concept analysis developed by Rodgers to elucidate the structure of HL in individuals with MS, defining HL as a multifaceted and dynamic concept. Data derived from diverse studies further corroborates this definition.4 In another study, Dehghani conducted a cross-sectional study examining the relationship between HL and stress, anxiety and depression in individuals with MS, revealing that heightened HL correlated with reduced stress levels.5 Claflin et al reported that MS-related knowledge was not associated with resilience, HL, self-efficacy, quality of life or symptom severity in people living with MS.6 In this study, our primary aim is to evaluate HL in patients diagnosed with MS and to examine associations of cognitive, emotional and demographic factors with HL, and the relationship between HL and illness perception. Although prior studies have explored HL in MS, our study uniquely combines HL assessment with patient-reported illness perception, emotional well-being and cognitive status in a Turkish MS cohort. Materials and methods Study population, study design, settings and participants Between April and September 2023, we conducted a single-centre, cross-sectional study that consecutively enrolled 330 patients with relapsing–remitting or progressive MS, diagnosed according to the 2017 McDonald criteria. The inclusion criteria were age between 18 and 65 years, functional literacy in Turkish (the ability to read and complete self-report questionnaires) and willingness to participate in the study. Participants were enrolled consecutively in the order of their admission to the MS outpatient clinic. Factors such as MS subtype, education period, degree of disability, medication usage and disease duration were not taken into account during enrolment. To facilitate data collection, a dedicated examination room was provided for individuals with MS to complete questionnaires. Various scales were administered, including the HL Scale, the Newest Vital Sign (NVS), the Montreal Cognitive Assessment (MoCA) Scale, the Hospital Anxiety and Depression Scale (HADS) and the Brief Illness Perception Questionnaire (BIP-Q). We also asked patients these questions: “Do you ever forget to take your MS medication?”, “Do you ever stop taking your medication when you feel better?”, and “Do you know the long-term benefits of taking your medication?” Patients answered yes or no to these questions. Following the initial participation of 330 individuals living with MS, 11 individuals were subsequently excluded from the study due to incomplete questionnaire responses or withdrawal from the study. Consequently, data from 319 patients were analysed. We reported the results in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology checklist (figure 1). Study enrolment flow chart. MS, multiple sclerosis. Instruments Newest Vital Sign NVS is a screening tool used to assess HL related to understanding and interpreting nutritional labels. It consists of six questions based on a food nutrition label and is designed to be quick and easy to administer. To assess the NVS, an individual is given a copy of a nutrition label from a hypothetical ice cream container and asked six questions related to the label. These questions test various aspects of HL, including numeracy, reading comprehension and interpretation of information. The responses given by the individual are then scored based on their ability to accurately interpret the provided nutritional information. A total score of 0–1 correct answer indicates a high likelihood (≥50%) of limited HL (inadequate). Scores of 2–3 correct answers suggest the possibility of limited literacy (marginal), reflecting uncertainty regarding the ability of an individual to accurately interpret health information. In contrast, scores of 4–6 correct answers almost always represent adequate HL, demonstrating sufficient capacity to understand and use basic health information. Çiftçi et al validated the Turkish adaptation of the NVS to evaluate HL and established a cut-off point of 4 for the Turkish population.7 Montreal Cognitive Assessment Scale The MoCA is a rapid screening tool that assesses mild cognitive impairment across various cognitive domains. Numerous researchers have extensively used the MoCA to evaluate cognition in individuals with MS.8 9 Scores on the test range from 0 to 30, with cut-off points varying across societies.9,11 For the Turkish population, scores of 21 and above are deemed to fall within normal limits.12 Hospital Anxiety and Depression Scale Given the clinically relevant burden of depressive symptoms in MS (with substantial variability across cohorts), the recognition and treatment of this comorbidity are of paramount importance.13 14 Various assessment tools are used for this purpose. We used the HADS in this study, a tool that has provided valuable insights in numerous studies by screening anxiety and depression in people with MS.15,17 It comprises 14 items, with symptoms rated on a scale of 0 to 3. Scores equal to or greater than 11 on either the anxiety or depression subscale denote a clinically significant condition, with a maximum attainable score of 21 for each subscale. Adaptation of the scale to the Turkish version and validity–reliability analyses were conducted by Aydemir et al.18 Brief Illness Perception Questionnaire The BIPB-Q comprises nine items that rate the cognitive and emotional perceptions of illness of individuals on a scale from 0 to 10. It assesses various aspects, such as the impact on life, illness duration, control, beliefs about treatment effectiveness, symptom experience, emotional representations, illness comprehensibility and perceived threat. Total scores range from 0 to 80, with higher scores indicating a more threatening perception of the illness.19 There are a limited number of studies on the role of disease perception in MS.20,22 A study on the validity and reliability of the Turkish scale was conducted in periodontal disease patients by Onder et al.23 Statistical analysis The data were analysed using IBM SPSS V.23 and IBM SPSS AMOS V.24 (IBM Corp, Armonk, NY, USA). A sample size calculation was conducted using G*Power V.3.1.9.6 software. We planned a multiple linear regression predicting HL (NVS total score) from seven predictors (age, duration of illness, education, MoCA, HADS-Dep, etc); a priori G*Power indicated n=252 for f²=0.062, α=0.05 and power=0.95. We fitted a path model using structural equation modelling (SEM) in AMOS with maximum likelihood estimation to quantify the standardised direct effects (β) of age, disease duration, education level, MoCA score, and hospital anxiety and HADS-D score on HL, as well as the effect of HL on the BIP-Q. Standardised coefficients (β), p values and coefficients of determination (R²) were reported. Post hoc analysis revealed that the achieved power of the test was 98.4%.24 The Kolmogorov‒Smirnov test was used to assess the normal distribution fit of the data. SEM was used to examine the impact of the MoCA score, education, age, disease duration and HADS score on quality of life, as well as the influence of quality of life on the BIP-Q score. Pearson’s χ² test was used to evaluate the relationships between variables. Our analysis reported the quantitative variables as the mean±SD and presented the categorical variables as frequencies and percentages. We interpreted all findings with a p value <0.05 as statistically significant. Results We analysed 319 pwMS with complete datasets after enrolling 330 individuals and excluding 11 due to incomplete data or withdrawal (figure 1). Tables1 2 summarise the descriptive characteristics of the cohort. The sample consisted of 228 females (71.6%), with a mean age of 39.0±10.7 years and a mean disease duration of 8.5±6.8 years. The median EDSS score was 3 (IQR: 1–6.5). Participants had an average of 11.7±4.6 years of education and used a median of two daily medications (range: 1–3). The mean HL score was 3.4±1.9, and 49.7% of participants demonstrated adequate HL, while 30.6% had marginal and 19.7% had inadequate levels. The mean BIP-Q total score was 44.6±12.5, with 42.2% categorised as low, 22.2% as moderate and 35.6% as high. The mean MoCA score was 24.2±3.7; 85.6% scored ≥21. The mean HADS-Depression and HADS-Anxiety scores were 5.5±3.9 and 7.0±3.9, respectively. Table 1Descriptive statistics of Brief Illness Perception Questionnaire (n=319) of patientsMean±SDNumber of medications2.4±1.9HADS-Anxiety total scores7.0±3.9Consequences5.5±2.7Timeline2.2±2.6Personal control6.4±2.9Treatment control7.8±2.6Identify5.1±2.7Concerned4.6±3.1Coherence8.6±2.2Emotional representation4.5±3.1HADS, Hospital Anxiety and Depression Scale. Descriptive statistics of Brief Illness Perception Questionnaire (n=319) of patients HADS, Hospital Anxiety and Depression Scale. Table 2Descriptive statistics and correlation analysis resultsMean±SDAgeDisease durationEducationMoCAHADS-DepressionHLBIP-QAge (years)39.0±10.7Disease duration (years)8.5±6.80.488Education11.7±4.6 −0.358 −0.082MoCA24.2±3.7 −0.400 −0.193 0.453HADS-Depression5.5±3.90.1450.070 −0.248 −0.149 HL3.4±1.9 −0.391 −0.245 0.4700.446 −0.302 BIP-Q44.6±12.5 −0.150 −0.0360.1600.032 −0.440 0.239Bold fonts indicate statistically significant correlations.BIP-Q, Brief Illness Perception Questionnaire; HADS, Hospital Anxiety and Depression Scale; HL, health literacy; MoCA, Montreal Cognitive Assessment. Descriptive statistics and correlation analysis results Bold fonts indicate statistically significant correlations. BIP-Q, Brief Illness Perception Questionnaire; HADS, Hospital Anxiety and Depression Scale; HL, health literacy; MoCA, Montreal Cognitive Assessment. Medication adherence responses indicated that 78% of participants reported never forgetting their MS treatment, 81% reported not stopping medication when feeling better and 93% reported knowing the long-term benefits of treatment. Correlation analysis identified significant associations among the variables (table 2). HL correlated positively with BIP-Q (r=0.239, p<0.001) and MoCA (r=0.446, p<0.001) and negatively with HADS-Depression (r = –0.302, p<0.001). BIP-Q also correlated negatively with HADS-Depression (r = –0.440, p<0.001). MoCA demonstrated a weak negative correlation with HADS-Depression (r = –0.149, p=0.008). Disease duration showed no significant correlation with education level, HADS scores or BIP-Q. Path analysis further clarified these relationships (figure 2, table 3). Higher MoCA scores were associated with increased HL (β=0.117, p<0.001), and greater education levels similarly with increased HL (β=0.114, p<0.001). Conversely, increasing age, longer disease duration and higher HADS-Depression scores were associated with reduced HL (β = –0.023, –0.029 and –0.085, respectively). Higher HL was associated with significantly increased BIP-Q scores (β=1.558, p<0.001). The structural equation model explained 35.6% of the variance in HL and 5.7% of the variance in BIP-Q. Path analysis results (A: non-standard path coefficients; B: standard path coefficients). BIPS-Q, Brief Illness Perception Questionnaire; HADS, Hospital Anxiety and Depression Scale; HL, health literacy; MoCA, Montreal Cognitive Assessment. Table 3Path analysis resultsβ0β1SECRPR2HL<---MoCA0.2270.1170.0274307<0001*0.356HL<---Education0.2700.1140.0225081<0001*HL<---Age−0.127−0.0230.010−2.230 0.026 * HL<---Disease duration−0.105−0.0290.015−2.013 0.044 * HL<---HADS-Depression−0.175−0.0850.023−3.768<0001*BIP-Q<---HL0.23915580.3554381<0001*0.057*Indicate statistically significant p values.(p<0.05)BIP-Q, Brief Illness Perception Questionnaire; CR, critical ratios; HADS, Hospital Anxiety and Depression Scale; HL, health literacy; MoCA, Montreal Cognitive Assessment; β0, standard coefficient; β1, unstandardised coefficient. Path analysis results Indicate statistically significant p values.(p<0.05) BIP-Q, Brief Illness Perception Questionnaire; CR, critical ratios; HADS, Hospital Anxiety and Depression Scale; HL, health literacy; MoCA, Montreal Cognitive Assessment; β0, standard coefficient; β1, unstandardised coefficient. Discussion To our knowledge, this is the first study to comprehensively explore the cognitive, emotional and demographic correlations of HL and its relationship with illness perception in individuals with MS, using patient-reported outcomes. Our findings revealed that cognitive performance, depressive symptoms, age and disease duration are significant determinants of HL, and that higher HL is positively associated with illness perception scores, which may reflect heightened awareness or concern regarding the illness. These insights contribute to a growing body of research highlighting the pivotal role of HL in improving patient outcomes, particularly in chronic conditions such as MS. In line with existing literature, our study further explored how cognitive, emotional and demographic factors interact to influence HL levels in individuals with MS.25 26 Given these associations, HL has increasingly attracted attention in chronic conditions, where improving the understanding of patients can strengthen the reliability of patient-reported outcomes. Claflin et al organised an online training programme for a large MS community cohort (people living with MS, caregivers and healthcare providers) and evaluated participants using an online survey before the training, immediately after completing it and again 6 months later. Researchers have examined the relationships between MS-related knowledge, HL, self-efficacy, resilience, quality of life and MS symptom severity in this large group of MS community members. The study demonstrated that MS knowledge did not correlate with resilience, HL, self-efficacy, quality of life or symptom severity in people living with MS, indicating that educational interventions focused solely on increasing knowledge may be insufficient to improve health-related outcomes within the MS community.6 In another study, Dehghani compared the effects of peer and lecture-based education on HL in people with MS and reported that peer group experiences were more effective than lecture-based education in improving HL. Similarly, using the successful experiences of peer patients as an educational support method for people living with MS may increase HL and quality of life.25 With technology becoming an integral part of our daily lives, it has become possible to evaluate the use of technology and the e-HL of individuals. In this context, a study conducted among people with MS assessed the e-HL of technology users and non-users and examined its relationship with demographic factors such as age, disease duration, gender, marital status and education level. The findings revealed that participants who used tablets and recommended websites had significantly higher e-HL scores compared with non-users. Researchers observed weak but significant correlations between e-HL scores and age, marital status and education level. These results highlight the importance of increasing digital access and providing education on e-HL to improve clinical management and rehabilitation in people with MS. Enhancing HL can help address misinformation and support better health outcomes for individuals with MS.26 Studies have shown that the overall education level of a society can directly influence HL and, consequently, community health outcomes. Limited HL is prevalent not only among individuals living with chronic conditions such as MS but also in a substantial portion of the general population (34%–59%).27 This underscores the need to address low HL at a societal level. For instance, researchers in Denmark conducted a study and reported that a significant segment of the population faced challenges in understanding health information and communicating effectively with healthcare providers.28 Similarly, Mancuso et al demonstrated among asthma patients that limited HL reduces participation in shared decision-making regarding their care.29 Individuals with low HL are less likely to use health-related information or benefit from preventive health services and therefore tend to use healthcare services more frequently, which can increase the burden on healthcare systems.29 Improving HL through patient-centred communication strategies and educational interventions may therefore help optimise healthcare use and promote more effective self-management among patients with MS. We assessed cognitive performance using MoCA scores, which also played a significant role in HL, emphasising the importance of incorporating cognitive assessments into routine MS care. In our study, education level emerged as the strongest predictor of HL, aligning with previous findings linking educational attainment and cognitive performance in MS.9 Although higher education levels consistently correlate with better HL, recommending a general increase in the education level of the population is neither practical nor immediately feasible, particularly in resource-limited settings. Instead, our findings highlight the importance of realistic, actionable strategies to improve HL in patients with MS. Such approaches may include routine HL screening (eg, NVS), plain language and teach-back communication techniques, visual and digital literacy support tools, and tailored counselling or decision aids for individuals with limited literacy. Implementing these interventions in clinical practice could enhance patient understanding, medication adherence and engagement in shared decision-making. The validity of the BIP-Q has been established across various chronic conditions, including diabetes, asthma, renal disease and cancer.29,32 However, literature presents mixed findings regarding the influence of HL on perceptions of illness among individuals. For instance, Perez et al reported in hypertensive patients that higher HL levels were associated with a less threatening perception of illness.33 Similarly, Ajuwon et al identified an inverse relationship between HL and illness perception among individuals with type 2 diabetes.34 In contrast to these studies, we observed a positive association between HL and illness perception in our cohort. MS is more prevalent among younger individuals, who are also frequent users of digital communication platforms. The vast amount of health-related content and the potential for misinformation available online can shape the understanding of their illness among patients, sometimes in misleading ways.35 36 People living with MS often demonstrate active information-seeking behaviour and explore alternative treatment approaches both before and after diagnosis.37 Altunişık et al reported that individuals with MS are more active on digital platforms than the general population, with the Internet serving as their primary source of health-related information.38 These findings underscore the significant role of digital platforms, particularly the Internet, in providing information and support for people with MS. However, the accessibility, abundance and sometimes contradictory nature of online information may also lead patients, especially those exposed to inaccurate or excessive content, to perceive their condition as more threatening. Understanding the information-seeking behaviours of people with MS can therefore help healthcare professionals tailor communication, educational materials and support resources to their specific needs. Additionally, clinicians should assess individuals with limited HL individually and design educational strategies that align directly with the comprehension capacity and educational background of each patient. The strength of our study is that it is the first study to investigate the direct and indirect effects of HL on disease perception in people living with MS. Given the multifactorial nature of the relationship between HL and illness perception, this area warrants further in-depth investigation. However, our study has several limitations. It may be important to evaluate potential differences in HL, disease perception and medication use behaviours of patients between different MS subtypes, address deficits in HL in specific MS subgroups and tailor interventions accordingly. In this context, one of the limitations of our study is that we did not perform a specific analysis of MS subtypes. We will consider this in our future research efforts and aim to provide a more comprehensive understanding of how HL and related factors vary in different MS subpopulations. Second, although we recruited patients from various provinces and regions, our study included only a single centre, which may limit the generalisability of the findings. Additionally, owing to its cross-sectional nature, our study provides less definitive insights into cause-and-effect relationships than cohort studies. Addressing these limitations in subsequent investigations will be crucial for advancing our understanding of HL dynamics in MS patients. In summary, our findings highlight the value of routine HL assessments using tools like the NVS to identify patients with limited HL and provide tailored interventions. Additionally, promoting e-HL initiatives could address the increasing reliance on digital platforms for health information. Digital literacy education can empower patients to discern credible information, reducing the psychological burden of misinformation and enhancing self-management capabilities. However, while increased HL has clear benefits, it may also exacerbate illness perception, as seen in this study. Higher HL can heighten awareness of disease complexities and potential risks, contributing to a greater perceived threat. This highlights the need for balanced educational strategies that provide comprehensive knowledge while mitigating excessive worry. Training healthcare providers in empathetic communication can play a key role in achieving this balance. Conclusion Our findings demonstrate that HL in individuals with MS is closely linked to cognitive performance, educational attainment and illness perception, indicating an interconnected relationship between cognitive, educational and emotional factors. Assessing the HL of patients at the initial clinical encounter and providing targeted support, when necessary, can substantially improve their understanding of disease processes, treatment options and preventive strategies, thereby facilitating shared decision-making and reducing misunderstandings. Promoting e-HL and digital education initiatives may further empower patients to identify credible information sources, minimise misinformation and enhance self-management skills. While higher HL generally yields positive outcomes, it may also heighten illness perception by increasing awareness of disease complexities. This underscores the need for balanced, patient-centred educational strategies and empathetic communication from healthcare professionals. Future studies should use longitudinal designs to evaluate the sustained impact of HL interventions and to explore the diverse needs of different MS subpopulations. Acknowledgements This work is part of a master’s thesis in the master’s programme in 2022 at Dresden International University, Dresden, Germany. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Patient consent for publication: Not applicable. Ethics approval: This study involves human participants and was approved by the Bursa Uludağ University Faculty of Medicine Ethics Committee (2022-18/25). Participants gave informed consent to participate in the study before taking part. Provenance and peer review: Not commissioned; externally peer reviewed. Data availability statement Data are available upon reasonable request. References Associated Data Data Availability Statement Data are available upon reasonable request.